MEDICAL COLLEGES REFORM TO ADDRESS ACCESSIBILITY, AFFORDABILITY AND RURAL CHALLENGES Priority given to new trainee candidates who come from rural backgrounds and have relevant experience
With
Jodie Long, CEO
Council of Presidents of Medical Colleges (CPMC)
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Melbourne | September 2025
The Council of Presidents of Medical Colleges (CPMC) is the peak body for Australia’s specialist medical colleges. CPMC provides a voice in the areas such as workforce issues, quality of healthcare and patient safety, and the education and training of specialist doctors.
Australia’s specialist medical colleges are introducing significant changes to their training selection processes to tackle the ongoing shortage of specialist doctors in rural and remote areas. The Council of Presidents of Medical Colleges (CPMC), in collaboration with the National Rural Health Commissioner, has unveiled new guidelines that prioritise candidates with rural backgrounds and experience during trainee selection.
Associate Professor Sanjay Jeganathan, Chair of CPMC, stated, “Too many rural Australians are waiting too long for specialist care or having to travel vast distances.” Research shows that doctors from rural areas are more likely to return and practice in those communities. The new framework systematically rewards candidates with relevant rural experience, including those who spent their childhood in rural settings, medical students who completed over 12 months of rural placements, and junior doctors who worked in rural hospitals.
The initiative reflects unprecedented collaboration among Australia’s specialist medical colleges, moving from good intentions to systematic change. “Every college will now use consistent definitions and transparent processes,” added A/Prof Jeganathan.
In tandem with these changes, CPMC is reforming its governance structure to better address workforce shortages and access challenges. This revised structure includes a Representative College Council and a separate Board of Directors, promoting agile decision-making and clearer communication with stakeholders. Dr. Jeganathan emphasised the importance of creating a unified voice for specialist doctors to respond effectively to urgent healthcare reforms, enhancing the organisation’s accountability and responsiveness.
Australian Health Journal spoke to CPMC CEO Jodie Long about some of the findings and challenges in the workforce within regional and rural settings and how the new governance structure will support representation of the 16 colleges to Government bodies.
Source: Adapted from CPMC media releases
-
Improvements in dental literacy and greater clinical insights through digital technology
Dr. Kenneth Soh is a General Dentist based in Kellyville, New South Wales, a suburb located in northwestern Sydney. Originally from Melbourne, he studied Bachelor of Dental Science (BDSc) at Melbourne University and graduated in 2003. After working for a year in the Mornington Peninsula, Dr. Soh moved to New South Wales, initially thinking it would be temporary; however, he has been there for 19 years. While he has considered specialising, he finds joy in all aspects of dentistry.
-
Early detection & surveillance guides for pancreatic cancer
Pancreatic cancer remains one of Australia’s deadliest cancers, with five-year survival rates hovering at just 14%, with little improvement over several decades. Often called the ‘silent killer’, the disease frequently presents with minimal or vague symptoms, resulting in late diagnoses and poor outcomes. Pancare Foundation is leading the rollout of new clinical resources and surveillance guides to support healthcare professionals in identifying at-risk patients and promoting early detection.
-
Medicinal cannabis in Australia Update
According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy.
Australian Health Journal met with 3 speakers at the recent ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.
